• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (56453371)   Find a Category (125)   Find a Journal (7882)   Find a Contributing Scholar (3656)   Find an Academic Assistant (52)
Find an Article PDF (4692549)   Today's Articles (6641)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
Article Statistics
Refine
For: Matsumoto D, Naiki T, Naiki‐Ito A, Aoki M, Kato S, Morikawa T, Shimizu N, Gonda M, Umemoto Y, Yasui T. Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases. IJU Case Rep 2025;8:5-9. [PMID: 39749291 PMCID: PMC11693097 DOI: 10.1002/iju5.12786] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 09/06/2024] [Indexed: 01/04/2025]  Open
Number Cited by Other Article(s)
1
Kato M. Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases". IJU Case Rep 2025;8:9-10. [PMID: 39749297 PMCID: PMC11693093 DOI: 10.1002/iju5.12805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2025]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA